Regular salmeterol vs salbutamol
Asthma‐related non‐fatal serious adverse events ‐ children · patients with chronic asthma
Regular salmeterol showed no clear difference in asthma‐related non‐fatal serious adverse events ‐ children compared with regular salbutamol (low certainty).
1 finding from 1 review
- Regular treatment with salmeterol for chronic asthma: serious adverse events 2008 · Cochrane Headline outcomes onlyOR 1.04 [0.47, 2.31]3 studies · 1186 participantsLow